-
-
-
-
-
Contract Manufacturing : Recro announces acquisition of San Diego-based IRISYS
Breaking News
Rentschler Biopharma supports construction of Einstein centre
To implement the project, the ‘First 11’ campaign aims to motivate more companies to become sponsors
Digital retrofitting in pharma
Why flexibility is the future of pharmaceuticals
Lonza to expand drug product development in Switzerland
This investment will fund an additional aseptic flexible filling line for clinical supply of drug product in Stein
Delivering fixed-dose combination therapies with hard capsules: part I
In this article, authors Dr Jnanadeva Bhat and Ms Anita Solanki describe how fixed-dose combination therapies can be ...
BD glass syringes capable of storage at deep cold temperatures
An analysis of approximately 2000 syringes showed no negative impact on key product functions when stored at -20°C and ...
Almac and Queen’s University Belfast collaboration passes midpoint
The KTP project has achieved multiple successful outcomes including dissemination through peer-reviewed publication and ...
The new regulatory world for medical devices
Establishing an effective compliance strategy now ahead of the 2022 IVDR legislation is critical — because there’s ...
Metrion Biosciences expands into Cambridge headquarters
The 12,000 sqft facility more than doubles the company’s laboratory space
Evonetix granted patent for DNA data storage tech
The company’s DNA-on-chip platform uses individually controlled ‘virtual wells’ to enable either de-novo DNA ...
Glass or polymer? swissfillon and SiO2 collaborate to deliver the best of both worlds in high quality filling
Fill and finish CDMO swissfillon and material science company SiO2 gave a joint presentation at MC Live to explain how ...
Deciding on a chemistry, manufacturing and control strategy for biologic development
Khanh Ngo Courtney from Avomeen discusses what biopharmaceutical companies should keep in mind as they embark on their ...
Industry spotlight: packaging trends in turbulent times
As if Brexit, the scaled-up production of vaccines and spiralling demand for cold chain storage wasn’t enough, Dr ...
Boehringer Ingelheim and OBT advance oncology candidate
The Boehringer Ingelheim drug candidate was discovered in a partnership with Oxford BioTherapeutics and enabled by ...
Catalent to manufacture Phathom gastrointestinal medicine
P-CABs are a class of medicines that block acid secretion in the stomach
In Brief
Most Popular
Inspiration and Learning
People
- Pfizer announces appointment of Chief Business Innovation Officer
- Rentschler Biopharma appoints Chief Scientific Officer
- Optibrium appoints Prof Andy Black non-executive chair
- Centrient Pharmaceuticals announces Non-Executive Supervisory Board appointment
- Philippe Deecke appointed Chief Financial Officer of Lonza Group
- Avacta appoints Chief Scientific Officer of therapeutics division
- Dante Labs appoints Mark Van Oene to board of directors
- Ori Biotech expands board of directors and scientific advisory board
Reports
